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We describe a method for the direct sequencing of DNA amplified by the polymerase chain reaction (PCR). Biotin is introduced into one strand 
of the amplified DNA using a S-biotinylated PCR primer. The synthexised fragment is captured on an avidin-matrix and rendered single stranded, 
whereafter the nucleotide sequence of the immobilized strand is determined by the chain termination method. The method involves few and simple 
operations and is thus applicable to the analysis of human genes for routine diagnostic purposes. Here we applied the method for determination 
of the three-allelic polymorphism of the apolipoprotein E (apo E) gene. We were able to correctly identify the alleles in both homoxygous and 
heteroxygous samples. 
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1. INTRODUCTION 
The knowledge of the exact molecular defects causing 
inherited diseases, as well as predisposition to genetic 
disorders and cancer is increasing rapidly. Diagnostic 
methods for the direct detection of mutations in the 
human genes are consequently becoming increasingly 
important. 
The polymerase chain reaction (PCR) technique [l] 
allows the enrichment of specific DNA fragments from 
the human genome. Mutations may be detected by 
analysis of restriction site variation in the amplified 
fragments [2,3], by hybridization with allele-specific 
oligonucleotide probes [4] or by nucleotide sequencing. 
Sequence determination is the most informative ap- 
proach to genetic analysis, but the methods used for the 
direct sequencing of amplified DNA [5-B] involve 
manipulations that are difficult to carry out on a 
routine basis. 
This communication describes a convenient method 
for the sequencing of PCR-amplified DNA fragments. 
In this technique biotin is introduced into the 5’-end of 
the DNA fragments synthesized during the PCR [9]. 
The fragments are then captured on an avidin-matrix 
and directly sequenced on this solid support. We ap- 
plied the method to the analysis of the genetic variation 
of the apolipoprotein E (apo E). This protein plays an 
important role in the lipoprotein metabolism: it is both 
an integral component and a mediator of cellular up- 
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take of several lipoproteins [lo]. Three common 
isoforms of apo E (E2, E3 and E4), encoded by 3 dif- 
ferent alleles (~2, 63 and ~4), exist in the population. 
This genetic polymorphism of apo E may explain as 
much as 10% of the individual variation of serum 
cholesterol levels [l l] and is thus of major clinical 
significance. The fact that the three-allelic polymor- 
phism of apo E is due to single base substitutions at two 
DNA loci only 138 base pairs apart from each other, 
makes it a particularly favorable target for PCR 
analysis. 
2. MATERIALS AND METHODS 
2.1. DNA 
Venous blood samples were obtained from patients attending the 
Lipid Outpatient Clinic of the University Central Hospital of 
Helsinki. Apo E phenotyping was accomplished by isoelectric focus- 
ing [12]. Leukocytic DNA was extracted according to Bell et al. [13]. 
2.2. Oligonucleotides 
The four primers (Pl-P4) were synthesized on an Applied 
Biosystems 381A DNA synthesizer [ 141. A 5 ’ -amino group was added 
to the PCR primers P2 and P3 with the amino-link II reagent (Applied 
Biosystems). The amino group was biotinylated using sulfo-NHS- 
biotin (Pierce Chemical Co.) and purified by reversed-phase HPLC 
[15]. The sequencing primer (P2 or P3) was labelled with 
[Y-~‘P]~ATP and T4 polynucleotide kinase [16] to a specific activity 
of 4 x lo6 cpm/pm. 
2.3. Polymerase chain reaction 
The DNA (100 ng per sample) was amplified with the Pl and P4 
primers (final concentration 1 /tM) in 100 ~1 of a solution of 0.2 mM 
each of dATP, dCTP, dGTP, dlTP, 20 mM Tris-HCl, pH 8.8, 
15 mM (NI-I&S04, 1.5 mM MgCh, 0.1% Tween 20, 0.1 mg/ml 
gelatin and 2.5 units of Thermus aquaticus DNA-polymerase (Pro- 
mega or United States Biochemical Corp.) in a DNA thermal cycler 
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(Perkin-Elmer/Cetus) for 25 cycles of 1 min at 96’C and 2 min at 
65°C. A small aliquot (3 ~1 of a 1:lOO dilution) of this first PCR 
amplification mixture was transferred to a second PCR. This was car- 
ried out at the conditions described above and directed by a pair of 
nested primers (P2 and P3) one of which was 5’-biotinylated. 
2.4. wflnity-capture 
A 25 ,ul aliquot of the second amplification mixture was diluted to 
50 ~1 with 0.15 M NaCl, 20 mM Na-phosphate buffer, pH 7.5 (PBS), 
after which 5/tl of a 5% (w/v) suspension of avidin-coated 
polystyrene particles (0.8 pm, Baxter Healthcare Corp.) were added. 
The samples were kept at 20°C for 1 h. The particles were collected 
by centrifugation for 2 min in an Eppendorf centrifuge and were 
washed twice by vortexing with 1 ml of 15 mM NaCl, 1.5 mM Na- 
citrate, and twice with 1 ml of 0.1% Tween 20 in PBS. The particles 
were treated twice with 0.15 M NaOH for 15 min, at 37”C, followed 
by two washes with 0.1% Tween 20 in 50 mM NaCl, 40 mM Tris- 
HCI, pH 7.5 and a &al wash with 0.01% Tween 20 in SO mM NaCl, 
40 mM Tris-HCI, pH 7.5. 
2.5. Nucleotidr sequencing 
The chain termination method of Sanger [17] was applied. The par- 
ticles carrying the DNA template were suspended in 10 cl of 50 mM 
NaCl, 20 mM MgC12, 40 mM Tris-HCI, pH 7.5, containing 0.5-l 
pmol of the sequencing primer P2 or P3. The tubes were heated at 
65°C for 2 min and allowed to cool slowly to room temperature. One 
pl of 0.1 M dithiothreitol, 2 rl of 0.75 PM dCTP, dGTP, dTTP, 
0.5 ~1 of [ac”S]dATP (> 1000 Ci/mmol, Amersham) and 2 ~1 (3.25 
units) of T7 DNA-polymerase (Sequenase, United States Biochemical 
Corp.) were added and the tubes were kept at 22’C for 3 min. When 
using an end-labelled primer the labelling step was omitted by 
substituting the dNTPs with 2.5 ~1 of HtO. An aliquot (3.5 ~1) of the 
reaction mixture was transferred to 4 tubes containing 2.5 ~1 of chain 
termination mixture (80 FM dNTP, 8 PM ddNTP for the A and T 
reactions; 320 CM dNTP, 8 CM ddNTP for the C and G reactions). 
The tubes were incubated at 42°C for 6 min and the reaction was stop- 
ped by adding 4 ~1 of a solution containing 95010 formamide, 20 mM 
EDTA, 0.05% bromophenol blue and 0.05% xylene cyanol. The 
samples were denatured at 80% for 2 mitt and the particles were spun 
down for 2 min. The products of the chain termination reactions were 
run on 6% sequencing els for 2.5 h at 2500 V. The sequencing lad- 
ders were visualized by autoradiography (Kodak XAR film). 
3. RESULTS AND DISCUSSION 
3.1. Principle of the method 
The method described here is based on PCR amplifi- 
cation of the nucleotide sequence of interest using a 
primer biotinylated in its 5 ‘-end, which results in the 
production of 5 ’ -biotinylated DNA fragments [9]. The 
amplified fragments are captured on a solid matrix tak- 
ing advantage of the biotin-avidin interaction. The non- 
biotinylated strand of the captured DNA is released by 
denaturation and the nucleotide sequence of the re- 
maining immobilized strand is determined by the chain 
termination method (fig. 1). This approach facilitates 
purification of the amplified DNA from the PCR mix- 
ture, eliminating the interference caused by primers and 
the dNTPs in the sequencing reaction. 
3.2. Sequence analysis of the apolipoprotein E gene 
The method was applied for the identification of the 
genetic polymorphism of apo E. This polymorphism is 
due to single base substitutions at two loci in the coding 
area of the apo E gene (fig.2). The allelic frequencies of 
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Fig.1. Principle of the method. bio = biotinylated. 
~2, 63 and t-4 in various populations are approximately 
IO%, 75% and 15%, respectively [ll]. More than 90% 
of patients with type III h~erlipoproteinemia, a 
disorder characterized by xanthomatosis, premature 
I. . . 
&3 
mm- Cys - Arg --- 
-9-TGC- CGC -.I 
E4 ==- Arg - Arg --I 
- - - CGC CGC -.I 
c. PRIMER 
NUCLEOTIDE 
SEQUENCE NUMBERS 
Pl : 5’-AAGGAG~GAAGGCCTACAAAT 3615 - 3637 
P2 : 5’TCGCGGGCCCCGGCCTGGTACA 3893 - 3914 
P3 : S’GAACAACTGAGCCCGGTGGCGG 3649 - 3671 
P4 : S’GGATGGCGCTGAGGCCGCGCTC 4012 - 4034 
Fig.2. (A) The positions of the primers along the fourth exon of the 
apolipoprotein E gene. The positions of ammo acids 112 and 158 are 
also shown. The numbers in parentheses refer to the nucleotide se- 
quence [18]. The drawing is in scale. (B) Variable amino acid and 
nucleotide sequences of the alleles ~2, ~3 and 64 (the corresponding 
protein phenotypes are designated as E2, E3 and E4, respectively). 
(C) Nucleotide sequence of the primers. P2 was 5 ’ -biotinylated and 
P3 was used as the sequencing primer. For sequencing the opposite 
strand of the DNA P3 was 5’-biotinylated and P2 was the sequencing 
primer. Nucleotide numbering is according to Paik et al. ]18]. 
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atherosclerosis and hyperlipoproteinemia, are 
homozygous for the 62 allele [I 11. On the other hand the 
phenotype E4 (encoded by the A allele) seems to be 
associated with elevated serum cholesterol ievels and in- 
creased risk of atherosclerosis at the population level 
[ 111. Serum apo E phenotyping can be carried out by 
two-dimensional electrophoresis or isoelectric focusing 
combined with immunoblotting [ 1 I]. These techniques 
are laborious and do not permit analysis of rare (other 
than E2, E3 and E4) apo E variants known to exist 1. lo]. 
The present procedure was optimized to give clear se- 
quencing ladders. The homogeneity of the DNA frag- 
ment to be sequenced is the most crucial factor of the 
procedure. Low efficiency due to amplification of non- 
specific DNA is a frequent problem when amplif~ng 
fragments of genomic DNA. In our method, this was 
circumvented by carrying out two consecutive PCR 
amplifications with a nested set of primers in the second 
amplification [l]. The primers (fig.2) were chosen from 
the known sequence of the apo E gene [18]. The 
primary primers Pl and P4 were 328 base pairs apart on 
the apo E gene. The nested primers amplified a 265 base 
pair fragment over the region coding for amino acids 
112 and 158 (fig.2). 
The sequencing reactions were carried out on the im- 
mobilized DNA template essentiahy as for templates in 
solution. The amount of DNA produced in the PCR 
amplification was OS-5 pmol per reaction as estimated 
by the affinity-based hybrid collection method [9]. One- 
tenth to one-fourth of this amount was optimal for a se- 
quencing reaction with 0.5-I pmol of the sequencing 
primer. The label was introduced by primer elongation 
with 35S-labelled ATP prior to the termination reac- 
tions (fig.3) or alternatively using a terminally 32P- 
labelled sequencing primer (fig.4). In the latter case 
separate labelling and termination reactions in the se- 
quencing protocol were not required. The fact that the 
template was i~obilized on microparticles did not 
adversely affect the sequencing reactions. The primer 
annealing efficiency was comparable to that in solution. 
The same dNTP/ddNTP ratios could be used in both 
cases. 
The sequence adjacent to the sequencing primer was 
readable as well as the sequence up to 5-7 nucleotides 
from the 5’-biotin residue attaching the DNA fragment 
to the microparticle. The codons for the amino acids 
112 and 158 in apo E are located 75 and 2 13 nucleotides, 
respectively, from the P3 sequencing primer. Fig.3 
shows a sequencing ladder over this region. The se- 
quence corresponds to the homozygous phenot~e 
E2E2, in which the amino acid residues 112 and 158 
both are cysteines. Fig.4 shows a determination of the 
base variation at amino acid position 112 in two 
samples of the phenotypes E3E3 and E3E4. In this case 
the opposite strand of the DNA was analyzed. In the 
homozygous sample both alleles code for cysteine 
residues at position 112 and in the heterozygous ample 
AC TG 
Fig.3. Autoradiograph obtained from sequence analysis of im- 
mobilized, amplified apolipoprotein E DNA. The arrows indicate the 
polymorphic DNA loci. The genotype of the subject is ~2~2 
(phenot~e E2E2). 
the sequence corresponding to both an arginine and a 
cysteine residue at position 112 can be read. 
The present technique allows typing of all possible 
combinations of the three alleles. Variable sites, other 
than amino acids 112 and 158 of apo E, clustering in the 
73 
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Fig.4. Autoradiographs obtained from sequence analysis of the locus 
coding for amino acid residue 112 in apolipoprotein E from two 
samples with the phenotypes E3E3 (left) and E4E4 (right). The rele- 
vant lanes (A and G) of the sequencing el are shown. The arrows in- 
dicate the base responsible for the genetic polymorphism at amino 
acid position 112. A/A corresponds to the 63 homozygote and A/G 
corresponds to the 63~4 heterozygote. 
same region of the molecule have occasionally been 
reported [lo]. This technique makes feasible the detec- 
tion of such rare mutations as well as the identification 
of previously unknown mutations. 
4. CONCLUSION AND PROSPECTS 
Direct nucleotide sequence data allow an unequivocal 
diagnosis of a genetic defect. The method described in 
the present communication is suitable for automation. 
The PCR cycles are carried out automatically. Captur- 
ing of the amplified DNA on a solid support comprises 
a simple and efficient single-step purification of the 
DNA from the PCR mixture. Solid phase techniques 
are applicable to automatic sequencing procedures, as 
shown recently by Hultman et al. and Voss et al. 
[19,20]. We conclude that nucleotide sequencing of 
affinity-captured PCR-amplified DNA fragments is a 
promising approach to the routine diagnosis of genetic 
disorders. 
Acknowledgements: We thank Anne Jarvinen for excellent echnical 
assistance, Marina Bengtstrom and Maritta Putkiranta for the syn- 
thesis and biotinylation of the oligonucleotides and Jonathan 
Knowles and Anu Koivula for helpful discussions. This work was sup- 
ported by grants from the Finnish Academy of Sciences and the 
University ofHelsinki (K.A.S.). Patent applications relating to the 
method described here are pending. 
REFERENCES 
[1] Mullis, K.B. and Faloona, F.A. (1987) Methods Enzymol. 155, 
335-350. 
[2] Saiki, R.K., Scharf, S., Falcona, F., Mullis, K.B., Horn, G.T., 
Erlich, H.A. and Arnheim, N. (1985) Science 230, 1350-1354. 
[3] Kogan, S.C., Doherty, M. and Gitschier, J. (1987) N. Engl. J. 
Med. 317, 985-990. 
[4] Saiki, R.K., Bugawan, T.L., Horn, G.T., Mullis, K.B. and 
Erlich, H.A. (1986) Nature 324, 163-166. 
[5] Wong, C., Dowling, C.E., Saiki, R.K., Higuchi, R.G., Erlich, 
H.A. and Kazazian, H.H. (1987) Nature 330, 384-386. 
[6] Engelke, D.R., Hoener, P.A. and Collins, F.S. (1988) Proc. 
Natl. Acad. Sci. USA 85, 544-548. 
[7] Gyllensten, U.B. and Erlich, H.A. (1988) Proc. Natl. Acad. Sci. 
USA 85, 7652-7656. 
[8] Mitchell, L.G. and Merril, C.R. (1989) Anal. Biochem. 178, 
239-242. 
[9] Syvlnen, A.-C., Bengtstrom, M., Tenhunen, J. and Soderlund, 
H. (1988) Nucleic Acids Res. 16, 11327-l 1338. 
[lo] Mahley, R.W. (1988) Science 240, 622-630. 
[II] Davignon, J., Gregg, R.E. and Sing, C.F. (1988) 
Arteriosclerosis 8, l-21. 
[12] Ehnholm, C., Lukka, M., Kuusi, T., Nikkill, E. and Utermann, 
G. (1986) J. Lipid Res. 27, 227-235. 
[13] Bell, G.I., Karam, J.H. and Rutter, W.J. (1981) Proc. Natl. 
Acad. Sci. USA 78, 5759-5763. 
[14] Beaucage, S.L. and Caruthers, M.H. (1982) Tetrahedron Lett. 
22, 1859-1862. 
[15] Bengtstrom, M., Jungell-Nortamo, A. and Syvanen, A.-C. 
(1989) Nucleosides Nucleotides, in press. 
[16] Maxam, A.M. and Gilbert, W. (1980) Methods Enzymol. 65, 
499-523. 
[17] Sanger, F., Miklen, S. and Coulson, A.R. (1977) Proc. Natl. 
Acad. Sci. USA 74, 5463-5467. 
[18] Paik, Y.-K., Chang, D.J., Reardon, C.A., Davies, G.E., 
Mahley, R.W. and Taylor, J.M. (1985) Proc. Natl. Acad. Sci. 
USA 82, 3445-3449. 
[19] Hultman, T., Stahl, S., Hornes, E. and UhlCn, M. (1989) 
Nucleic Acids Res. 17, 4937-4946. 
[20] Voss, H., Schwager, C., Wirkner, U., Sproat, B., Zimmermann, 
J., Rosenthal, A., Erfle, H., Stegemann and Ansorge, W. (1989) 
Nucleic Acids Res. 9. 25 17-2527. 
74 
